Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ZIOPHARM Oncology Inc (NASDAQ:ZIOP)

6.23
Delayed Data
As of 4:14pm ET
 +0.16 / +2.64%
Today’s Change
4.45
Today|||52-Week Range
7.88
+16.45%
Year-to-Date
No recent news for ZIOPHARM Oncology Inc.

Today’s Trading

Previous close6.07
Today’s open6.05
Day’s range5.99 - 6.34
Volume1,824,642
Average volume (3 months)1,403,474
Market cap$862.5M
Dividend yield--
Data as of 4:14pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)+55.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+58.38%
P/E ratioNM
Price/Sales101.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.80+4.29%
ATNXAthenex Inc+0.18+1.20%
HRTXHeron Therapeutics I...-0.35-2.27%
CLLSCellectis SA+1.57+6.78%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$6.9M
Annual profit (last year)-$165.3M
Net profit margin-2,409.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Managing Director
Laurence James Neil Cooper
COO, Secretary, Chief Legal Officer &
Executive VP
Caesar J. Belbel
Corporate headquarters
Boston, Massachusetts

Forecasts